Since CD11b+ cells are known to enhance angiogenesis [19] and play a major role in inflammatory and reparative processes after tissue injury, further potentially angiogenic subsets of CD11b+ cells were analyzed at day 2 and day 7 after MI ± DMOG treatment, reflecting the early and late phase of inflammatory response after myocardial infarction with the major impact on cell infiltration [20, 21]. Here, ITGAM is linked to myocardial infarction.